CynergisTek to Host a Conference Call on Monday, May 16, 2022 to Discuss First Quarter 2022 Financial Results

AUSTIN, Texas–(BUSINESS WIRE)–CynergisTek (NYSE AMERICAN: CTEK), a leading cybersecurity, privacy, compliance and IT audit firm that helps organizations in highly regulated industries address emerging security and privacy issues, announced today that management will host a conference call at 4:30 p.m. Eastern Time. It’s time on Monday, May 16, 2022 to discuss the first quarter 2022 financial results. The results will be released before the call.

When: Monday, May 16, 2022

Time: 4:30 p.m. ET / 1:30 p.m. PT

USA: 1-888-394-8218

International: 1-786-789-4776

Conference ID: 8001259

Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=W6CXE7Cj

A replay of the call will be available from 7:30 p.m. ET on May 16, 2022 to 11:59 p.m. ET on May 23, 2022. To access the replay, please dial 1-844-512-2921 from within the United States and 1-412-317-6671 from outside the US The PIN is 8001259.

About CynergisTek, Inc.

CynergisTek is a leading cybersecurity consulting firm that helps organizations in highly regulated industries, including healthcare, government and finance, address emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate an organization’s security posture and ensure the team is primed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real world experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or LinkedIn.

Caution Regarding Forward-Looking Statements

This press release contains certain forward-looking statements relating to CynergisTek’s business. These forward-looking statements have the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act” ) and can be identified by the use of forward-looking terminology such as “believes”, “expects”, “anticipates”, “would”, “could”, “intends”, “may” , “will” or similar expressions. These forward-looking statements involve known and unknown risks and uncertainties, including, but not limited to, uncertainties related to product/service development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other suppliers; the ability of the Company’s suppliers to continue to provide the Company with supplies and services on comparable terms and at comparable prices; the Company’s ability to successfully compete and introduce enhancements and new features that gain market acceptance and keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace significant customers; cybersecurity risks and risks of damage to and interruptions of computer systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new businesses, divestitures, mergers or other transactions on acceptable terms, or not at all; the potential risks and uncertainties related to the current and ultimate impact of the COVID-19 pandemic, including measures that may be taken by governmental authorities to contain the COVID-19 epidemic or to address its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets; the general economic impact of the ongoing war in Ukraine, including the impact of related sanctions imposed by the U.S. government and governments of other countries, and the impact of potential retaliation as a result of the war in Ukraine and any related sanctions; and other factors that may cause actual results to differ materially from those described herein as anticipated, believed, estimated or expected. Some of these risks and uncertainties are or will be described in more detail in the Company’s Forms 10-K and 10-Q filed with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on forward-looking statements and should recognize that statements are predictions of future results which may not occur as expected. Many of the risks listed above have been, and could further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare sector, or the ongoing war in Ukraine. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not currently anticipated. CynergisTek has no obligation (and expressly disclaims any such obligation) to update or change its forward-looking statements, whether as a result of new information, future events or otherwise.

Michael P. Boser